Expertise in
18
conditions

Dr. Scott D. Brook

Oncology
Bucher Hematology/Oncology Inc.
1180 N Indian Canyon Dr Ste E218, 
Palm Springs, CA 
Expertise in
18
conditions
Bucher Hematology/Oncology Inc.
1180 N Indian Canyon Dr Ste E218, 
Palm Springs, CA 

Overview

Scott Brook is an Oncologist practicing medicine in Palm Springs, California.

Dr. Brook is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Ampullary Cancer, Breast Cancer, Bone Tumor, and Paget Disease of the Breast.

He is actively involved in clinical research, participating in 3 clinical trials.

Specialties

Oncology

Licenses

Internal Medicine in CA

Hospital Affiliations

Desert Regional Medical Center
Eisenhower Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

HealthPartners
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Inland Empire Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

Bucher Hematology/Oncology Inc.
1180 N Indian Canyon Dr Ste E218, Palm Springs, CA 92262

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

(CompassHER2-pCR): Preoperative THP and Postoperative HP in Patients Who Achieve a Pathologic Complete Response
(CompassHER2-pCR): Preoperative THP and Postoperative HP in Patients Who Achieve a Pathologic Complete Response
Enrollment Status: Active_not_recruiting
Publish Date: July 10, 2026
Intervention Type: Procedure, Biological, Drug, Radiation
Study Drugs: Docetaxel, Nab-Paclitaxel, Paclitaxel, Pertuzumab, Trastuzumab, Trastuzumab Emtansine
Study Phase: Phase 2
A Randomized, Double-Blind, Phase III Trial of Taxane/Trastuzumab/Pertuzumab With Atezolizumab or Placebo in First-Line HER2-Positive Metastatic Breast Cancer
A Randomized, Double-Blind, Phase III Trial of Taxane/Trastuzumab/Pertuzumab With Atezolizumab or Placebo in First-Line HER2-Positive Metastatic Breast Cancer
Enrollment Status: Terminated
Publish Date: May 29, 2026
Intervention Type: Other, Procedure, Biological, Drug
Study Drugs: Atezolizumab, Paclitaxel, Pertuzumab, Trastuzumab
Study Phase: Phase 3
Olanzapine With or Without Fosaprepitant for the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV)in Patients Receiving Highly Emetogenic Chemotherapy (HEC): A Phase III Randomized, Double Blind, Placebo-Controlled Trial
Olanzapine With or Without Fosaprepitant for the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV)in Patients Receiving Highly Emetogenic Chemotherapy (HEC): A Phase III Randomized, Double Blind, Placebo-Controlled Trial
Enrollment Status: Completed
Publish Date: April 06, 2025
Intervention Type: Other, Drug
Study Phase: Phase 3
View 2 Less Clinical Trials
Similar Doctors
Expertise in
54
conditions
Expertise in
54
conditions
Referral may be required

Eisenhower Lucy Curci Cancer Center

39000 Bob Hope Dr, 
Rancho Mirage, CA 
 (11.5 miles away)
760-674-3602
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Constantin Dasanu is an Oncologist practicing medicine in Rancho Mirage, California. Dr. Dasanu is highly rated in 54 conditions, according to our data. His clinical expertise encompasses Neuroendocrine Tumor, Melanoma, Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET), Merkel Cell Carcinoma, and Bone Marrow Aspiration.

Expertise in
10
conditions
Expertise in
10
conditions
Referral may be required

Eisenhower Health

39000 Bob Hope Dr, 
Rancho Mirage, CA 
 (11.5 miles away)
760-674-3604
Languages Spoken:
English
See accepted insurances

Steven Plaxe is an Oncologist practicing medicine in Rancho Mirage, California. Dr. Plaxe is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Ovarian Cancer, Ovarian Carcinosarcoma, Sertoli-Leydig Cell Tumor, and Salpingo-Oophorectomy.

Expertise in
52
conditions
Expertise in
52
conditions
Referral may be required

Eisenhower Health

39000 Bob Hope Dr, 
Rancho Mirage, CA 
 (11.5 miles away)
760-341-3688
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Davood Vafai is an Oncologist practicing medicine in Rancho Mirage, California. Dr. Vafai is highly rated in 52 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Anal Cancer, Lung Adenocarcinoma, Small Cell Lung Cancer (SCLC), and Bone Marrow Aspiration.

Frequently Asked Questions about Dr. Scott D. Brook

How do I make an appointment with Dr. Scott D. Brook?

You can book an appointment with Dr. Scott D. Brook by calling their office at 760-416-4721. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Scott D. Brook a top-rated expert for Ampullary Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Scott D. Brook is classified as an Distinguished expert for Ampullary Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Scott D. Brook specialize in?

While Dr. Scott D. Brook is a Oncology, they have specific expertise in Ampullary Cancer, Breast Cancer, and Bone Tumor. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Scott D. Brook accept my insurance?

Dr. Scott D. Brook accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 760-416-4721 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Brook's expertise for a condition
ConditionClose
    View All 16 Advanced Conditions
    View All 63 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile